Evidence from Japan suggests that the early diagnosis of gastric cancer greatly improves the prognosis, with a 96% five year survival compared with 2% in advanced disease. 7 In the United Kingdom, few cases of early gastric cancer are diagnosed endoscopically.8 There is little information about detecting people at increased risk of developing upper gastrointestinal malignancy although there are a number of conditions that are known to predispose to cancer. These include Barrett's oesophagus, atrophic gastritis, previous gastric surgery, sporadic gastric and duodenal adenomas, familial adenomatous polyposis (FAP), and Peutz-Jegher syndromes.
Omithine decarboxylase (ODC) activity has been suggested to be a biochemical marker of cellular proliferation.9 ODC is a cytoplasmic enzyme, which catalyses the conversion of the polyamine omithine to putrescine. The polyamines are essential for regulatory functions in protein and nucleic acid synthesis and are thus vital for cell growth and differentiation. Increases in ODC activity may thus reflect an increased rate of macromolecular synthesis during cellular proliferation. Studies in mucosal biopsy specimens from patients with FAP have suggested that ODC is a useful marker for neoplastic potential.'0 An increase in ODC activity has been found in the colorectal mucosa in FAP, being comparatively low in morphologically normal mucosa and increasing with the development of adenomas and with dysplasia. Furthermore it was suggested that phenotypically normal relatives of FAP patients who possess the FAP genotype have increased colonic ODC activity, which precedes the development of morphological changes. 1 Increased ODC activity has also been reported in the morphologically normal mucosa of patients with sporadic colorectal adenomas'2 and in dysplastic Barrett's oesophageal mucosa.13 No studies on human gastric premalignant conditions have been reported. In this study, we have measured the ODC activity in the upper gastrointestinal tract in normal subjects, subjects at risk of gastric cancer, and patients with established gastric tumours, to assess its value as a potential biomarker of cancer risk.
Methods
One hundred and three consecutive patients coming to gastroscopy for clinical indications who fulfilled the diagnostic criteria were included in the study. Endoscopic findings 
Results
In the gastric mucosa of normal subjects, median ODC activity was 371 pmol/mg protein/h (interquartile range (IQR), 230-617). No variation with age was identified, and activities for men and women were similar (Table II) . Of the 32 subjects with no endoscopic abnormality on endoscopy, 18 were H pylori positive (56%) and 14 (44%) were H pylori negative. Of those patients who were H pylori positive, all had evidence of chronic active gastritis, six (33%) had gastritis with atrophy and two (11%) had focal intestinal metaplasia. Patients without H pylori infection had no histological abnormality. No significant difference in ODC activity between H pylori positive patients and Hpylori negative patients was noted. ODC activity in gastric mucosa from patients who had undergone gastric surgery was significantly increased compared with normal subjects (p=0.007) although there was some overlap between the two groups ( Figure) . In common with biopsy specimens from the normal stomach, ODC activity in the operated stomach was not related to age, or sex, and there was no correlation between ODC activity and time between surgery and endoscopic examination (r=0.3, p=NS). Nine patients had a Billroth 1 gastrectomy, 15 had a Billroth 2 gastrectomy, and eight patients had a vagotomy with a drainage procedure. The type of operation, however, did not influence ODC activity (Table III) . The median ODC activity in macroscopically In this study we have examined the value of ODC activity as a potential marker for malignant risk in the stomach by comparing ODC activity in the normal stomach, in conditions known to predispose to upper gastrointestinal malignancy, and in stomachs with a concomitant gastric malignancy. In the normal stomach, the range of ODC activities is comparatively wide and in contrast with some previous reports, we have not found any relation to age or sex. 20 The presence of H pylori, which is inevitably associated with chronic active gastritis and may play a part in the genesis of gastric cancer21 22 was also not found to influence ODC activity. This is in contrast with preliminary data, which suggests that mucosal proliferation assessed by immunohistochemical techniques may be increased by Hpylori colonisation. 23 As a group, patients with an operated stomach had a significantly higher ODC activity compared with normal controls, regardless of the nature of the gastric operation although there was some overlap between this group and controls. Perhaps most important, however, was the inability of ODC measurements to differentiate between patients at risk of gastric cancer, such as patients after gastric resection and patients with an established gastric cancer. Although ODC activity in both groups was greater than in controls, they were not significantly different from each other. This may in part be explained by the histological similarity of the macroscopically normal mucosa in these two groups. The presence of atrophy or metaplasia is associated with significantly higher ODC activity regardless of whether the specimen was from the postoperative stomach or from an area adjacent to a tumour. Neither ODC activity or histological examination from normal adjacent mucosa, however, could differentiate biopsy specimens from the postoperative stomach or a tumour bearing stomach. Furthermore, ODC activity in the stomach of patients with FAP, who are known to be at risk of upper gastrointestinal malignancy24 and who also commonly display histological abnormalities such as microadenoma formation were no different to control subjects. Thus the known increased malignant risk of this group of patients was not mirrored by an increase of ODC activity. The finding of a relation of ODC activity to defined histological abnormalities is interesting though unlikely to be useful clinically, as it is in the absence of definable morphological abnormalities that potential biomarkers of malignancy are likely to be of greatest value.
Initial studies on ODC activity in human gut tissue were extremely encouraging, suggesting that this comparatively simple bioassay could provide an accurate indicator of malignant potential, particularly in histologically normal tissue.10 Furthermore, it has been suggested that ODC activity could differentiate patients at increased genetic risk of colon cancer but with normal colons, from those at low risk." More recent studies of ODC activity in the large bowel have been less encouraging. Two recent studies have shown that the measurement of ODC activity was unable to differentiate patients with adenomatous polyps from normal subjects and was thus a poor indicator of cancer risk. '8 19 Variations in technique and expertise between laboratories may partly explain these anomalies though, even laboratories with considerable experience find considerable overlaps between groups. The handling and storage of tissues is felt to be an important factor in the observed variability but in this study all tissue was flash frozen and stored at -70°C. In addition all assays were performed within three weeks of tissue collection.
In summary, we have identified differences in gastric mucosal ODC activity between controls and certain disease states. We did not show any difference, however, in ODC activity between controls and patients with familial polyposis, or between patients with an operated stomach and those with a gastric tumour. Specific histological abnormalities such as atrophy and intestinal metaplasia are associated with increased polyamine biosynthetic activity but this is not specifically related to the clinical disease state. The inability to differentiate groups at risk of gastric malignancy from those with established cancer suggests that measurement of polyamine biosynthetic activity will probably not be a valuable clinical marker of increased cancer risk.
